Cytokine responses following intrapleural administration of oncolytic HSV SEPREHVIR® in patients with malignant pleural mesothelioma

被引：0
|
作者：
Learmonth, Kirsty [1 ]
Braidwood, Lynne [1 ]
Woll, Penella [2 ]
Conner, Joe [1 ]
机构：
[1] Virttu Biol, Glasgow, Lanark, Scotland
[2] Univ Sheffield, Teaching Hosp, Sheffield, S Yorkshire, England
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR15-B033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B033
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Oncolytic virus therapy for mesothelioma - a phase I trial of intrapleural seprehvir
    Woll, P. J.
    Danson, S. J.
    Edwards, J. G.
    Fisher, P. M.
    Conner, J.
    LUNG CANCER, 2013, 79 : S34 - S34
  • [2] A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma
    Sterman, DH
    Molnar-Kimber, K
    Iyengar, T
    Chang, M
    Lanuti, M
    Amin, KM
    Pierce, BK
    Kang, E
    Treat, J
    Recio, A
    Litzky, L
    Wilson, JM
    Kaiser, LR
    Albelda, SM
    CANCER GENE THERAPY, 2000, 7 (12) : 1511 - 1518
  • [3] A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma
    Daniel H Sterman
    Katherine Molnar-Kimber
    Tara Iyengar
    Michael Chang
    Michael Lanuti
    Kunjlata M Amin
    Brandon K Pierce
    Eugene Kang
    Joseph Treat
    Adri Recio
    Leslie Litzky
    James M Wilson
    Larry R Kaiser
    Steven M Albelda
    Cancer Gene Therapy, 2000, 7 : 1511 - 1518
  • [4] Neoadjuvant and Intrapleural Therapies for Malignant Pleural Mesothelioma
    Tsao, Anne S.
    Mehran, Reza
    Roth, Jack A.
    CLINICAL LUNG CANCER, 2009, 10 (01) : 36 - 41
  • [5] Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma
    Chintala, Navin K.
    Choe, Jennie K.
    McGee, Erin
    Bellis, Rebecca
    Saini, Jasmeen K.
    Banerjee, Srijita
    Moreira, Andre L.
    Zauderer, Marjorie G.
    Adusumilli, Prasad S.
    Rusch, Valerie W.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma - A phase II study
    Astoul, P
    Picat-Joossen, D
    Viallat, JR
    Boutin, C
    CANCER, 1998, 83 (10) : 2099 - 2104
  • [7] Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716
    Danson, Sarah J.
    Conner, Joe
    Edwards, John G.
    Blyth, Kevin G.
    Fisher, Patricia M.
    Muthana, Munitta
    Salawu, Abdulazeez
    Taylor, Fiona
    Hodgkinson, Elizabeth
    Joyce, Patrick
    Roman, Jennifer
    Simpson, Kathleen
    Graham, Alexander
    Learmonth, Kirsty
    Woll, Penella J.
    LUNG CANCER, 2020, 150 : 145 - 151
  • [8] Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma - A phase II study
    Karrison, TG
    Vogelzang, NJ
    CANCER, 1999, 86 (03) : 546 - 547
  • [9] Repeated ambulatory intrapleural chemotherapy for malignant pleural mesothelioma
    Javidfar, J.
    Sonett, J. R.
    Ginsburg, M. E.
    Miller, J.
    Hare, E.
    Bacchetta, M.
    Fawwaz, R.
    Taub, R. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion
    Foo, Chuan T.
    Paterson, Anna
    Duckworth, Adam
    Herre, Jurgen
    CHEST, 2021, 160 (06) : E609 - E611
12345